Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Coulter Partners. (7/5/18). "Press Release: Coulter Partners Secures Chief Executive Officer for Ovizio".

Organisations Organisation Coulter Partners (The Coulter Partnership Ltd.)
  Organisation 2 Ovizio Imaging Systems NV/SA
Product Product  microscope, optical
Index term Index term Ovizio–Coulter Partners: recruitment services, 201806 supply service placement of Emilie Viey as new CEO of Ovizio ImagingSystems
Persons Person Viey, Emilie (Ovizio Imaging Systems 201806– CEO before ACEA Biosciences + Roche Diagnostics France)
  Person 2 Buis, Philipp (Coulter Partners 201703– Executive Director in Zurich before Jauch Assoc + Ward Howell/Neumann Intl)

Coulter Partners was delighted to partner with Ovizio Imaging Systems, a life science imaging technology company, to secure the appointment of Dr. Emilie Viey as Chief Executive Officer and board member. Dr. Viey will lead Ovizio’s further development as solution provider for imaging applications in Life Sciences.

Emilie Viey joins Ovizio Imaging Systems from ACEA Biosciences, a Cell Analysis instruments company based in San Diego (USA), where she was Director of Commercialization and set up the complete organization for Europe. Before that, she was application scientist at Roche Diagnostics France for Cellular Analysis Instruments (Cell Counters, Imaging Platform and Label Free Cell Analyzers). Emilie holds a MSc. in Biochemistry and a PhD in Immunology.

Philip Mathuis, co-founder of Ovizio, who is stepping down as CEO, played a crucial role setting up the company and establishing its operations. He secured funding, developed a portfolio of products and recruited an outstanding team to move the organization to the next phase.

“Ovizio has a unique technology platform and product portfolio for automated label-free imaging of cells that offer the capability to fingerprint cells for a large number of applications”, says Dr. Viey. “I am convinced of the tremendous value Ovizio can bring to both traditional cellular bioprocessing and the most advanced cell therapy processes. I very much look forward to working with Ovizio’s team to further expand the company’s reach.”

“We are delighted to welcome Emilie to Ovizio and I thank the exceptional team at Coulter Partners for their work in achieving this high-calibre appointment. Emilie brings deep scientific knowledge, understanding and experience in cell based instrumentation, in addition to marketing and sales expertise,” adds Philippe Vercruyssen, Executive Chairman of Ovizio.

About Ovizio Imaging Systems

Ovizio is an innovative Belgian company developing efficient quantitative microscopy solutions for life sciences applications. Ovizio’s microscopes offer easy-to-use, label-free and non-invasive tools for real-time 3D and 4D imaging of living cells. Validated with almost every type of transparent cell culture vessel, Ovizio’s devices can track cell count, cell morphology and cell viability with the highest reproducibility at a single cell level. Applicable from R&D to manufacturing processes and enabling significant cost reductions and quality improvement, Ovizio’s microscopes are particularly convenient and robust for automated cell culture monitoring, analysis and quality control.

For more information, please visit:

KEY PLAYERS [at Coulter Partners]

Philipp Buis : Executive Director

Quentin Oerlemans : Senior Consultant

Bianca Coulter : CEO

Irene Montgomery : Director

Gemma Nash : Project Co-ordinator

Record changed: 2023-06-05


Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Coulter Partners (The Coulter Partnership Ltd.)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner German Biotech Days 2024 in Berlin 650x300px

» top